Los puntos clave no están disponibles para este artículo en este momento.
Though concerns about a potential conflict of interest remain paramount and must be addressed in any new system of reimbursement, oncologists believe reimbursement to enhance infrastructure could help overcome barriers to trial accrual.
Lee et al. (Fri,) studied this question.